8.25

0.61% 0.05

Pre-market: 8.61 0.36 +4.36%

Aligos Therapeutics Inc (ALGS)

Overview News Price History Option Chain Financials Why ALGS Down? Discussions Forecast

Aligos Therapeutics Inc stock is traded at $8.25, with a volume of 61,374. It is up +0.61% in the last 24 hours and down -15.82% over the past month. Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Previous Close:

$8.20

Open:

$8.18

24h Volume:

61,374

Relative Volume:

0.77

Market Cap:

$44.15M

Revenue:

$7.97M

Net Income/Loss:

$-75.74M

P/E Ratio:

-0.3397

EPS:

-24.2853

Net Cash Flow:

$-85.33M

1W Performance:

-14.82%

1M Performance:

-15.82%

6M Performance:

+47.85%

1Y Performance:

-15.64%

1-Day Range:

$8.07

$8.76

1-Week Range:

$8.07

$10.06

52-Week Range:

$3.76

$46.80

Aligos Therapeutics Inc Stock (ALGS) Company Profile

Name

Aligos Therapeutics Inc

Sector

Healthcare (1135)

Industry

Biotechnology (635)

Phone

(800) 466-6059

Address

ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

ALGS's Discussions on Twitter

Compare ALGS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALGS Aligos Therapeutics Inc	8.25	57.00M	7.97M	-75.74M	-85.33M	-24.29
VRTX Vertex Pharmaceuticals Inc	425.57	107.66B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	651.80	68.74B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	456.04	58.93B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	818.50	50.51B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	189.60	41.29B	447.02M	-1.18B	-868.57M	-6.1812

Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-18-25	Resumed	H.C. Wainwright	Buy
Aug-19-24	Initiated	H.C. Wainwright	Buy
Jan-06-23	Upgrade	Jefferies	Hold → Buy
Jan-06-23	Upgrade	Piper Sandler	Neutral → Overweight
Mar-23-22	Downgrade	Piper Sandler	Overweight → Neutral
Jan-07-22	Downgrade	JP Morgan	Overweight → Neutral
Jan-06-22	Downgrade	Jefferies	Buy → Hold
Sep-09-21	Initiated	SVB Leerink	Outperform
May-17-21	Resumed	Piper Sandler	Overweight
Nov-10-20	Initiated	Cantor Fitzgerald	Overweight
Nov-10-20	Initiated	JP Morgan	Overweight
Nov-10-20	Initiated	Jefferies	Buy
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Aligos Therapeutics Inc Stock (ALGS) Latest News

02:49 AM

How to build a dashboard for Aligos Therapeutics Inc. stock2025 Market Trends & Expert Curated Trade Ideas - newser.com

02:49 AM

01:53 AM

How to forecast Aligos Therapeutics Inc. trends using time seriesWeekly Profit Analysis & Free Weekly Chart Analysis and Trade Guides - newser.com

01:53 AM

Nov 02, 2025

Why Aligos Therapeutics Inc. stock remains on buy lists2025 Retail Activity & Safe Capital Growth Tips - newser.com

Nov 02, 2025

How buybacks impact Aligos Therapeutics Inc. stock valueWeekly Investment Recap & Free AI Powered Buy and Sell Recommendations - newser.com

Nov 02, 2025

Is Aligos Therapeutics Inc a good long term investmentChart Pattern Recognition & Free Rapid Return Acceleration - earlytimes.in

Nov 02, 2025

Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosTrade Entry Report & AI Enhanced Market Trend Forecasts - newser.com

Nov 02, 2025

Nov 01, 2025

Is Aligos Therapeutics Inc. stock positioned well for digital economy2025 Major Catalysts & Free Growth Oriented Trading Recommendations - newser.com

Nov 01, 2025

How Aligos Therapeutics Inc. (5WK0) stock stacks up against competitors2025 Risk Factors & Growth-Oriented Investment Plans - newser.com

Nov 01, 2025

Multi factor analysis applied to Aligos Therapeutics Inc.Trade Analysis Report & Real-Time Volume Surge Alerts - newser.com

Nov 01, 2025

Oct 31, 2025